XIAO LIU: Open Payments
NPI 1912483678 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $97 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| ABBVIE INC. | 3 | $51 |
| Novo Nordisk Inc | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Abbott Laboratories | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: NEXPLANON, REXULTI, VRAYLAR, MOUNJARO, CAPLYTA, Wegovy, FREESTYLE LIBRE 3, JARDIANCE.
Industry payments across NC — which companies pay providers there.
